You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for New Drug Application (NDA): 204822


✉ Email this page to a colleague

« Back to Dashboard


NDA 204822 describes IZBA, which is a drug marketed by Novartis and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge. Additional details are available on the IZBA profile page.

The generic ingredient in IZBA is travoprost. There are fifteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the travoprost profile page.
Summary for 204822
Tradename:IZBA
Applicant:Novartis
Ingredient:travoprost
Patents:4
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 204822

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrength0.003% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:May 15, 2014TE:RLD:Yes
Patent:⤷  Try a TrialPatent Expiration:Oct 10, 2029Product Flag?YSubstance Flag?Delist Request?
Patent:⤷  Try a TrialPatent Expiration:Oct 10, 2029Product Flag?YSubstance Flag?Delist Request?
Patent:⤷  Try a TrialPatent Expiration:May 19, 2029Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.